ORIGINAL RESEARCH
Accepted on 08 Apr 2025
A Comprehensive Pan-Cancer Analysis of LRFN4: Its Potential as a Prognostic Biomarker and Therapeutic Target for Immunotherapy
doi 10.3389/fimmu.2025.1539076
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune Predictive and Prognostic Biomarkers in Immuno-Oncology: Refining the Immunological Landscape of Cancer
Immune Predictive and Prognostic Biomarkers in Immuno-Oncology: Refining the Immunological Landscape of Cancer
3,196
Total downloads
11k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 04 Apr 2025
Deciphering ERR Family Genes as Prognostic and Immunological Biomarkers through Pan-Cancer Analysis with Validation in Gallbladder Cancer
doi 10.3389/fonc.2025.1525635
ORIGINAL RESEARCH
Published on 27 Mar 2025
Identification of a novel prognostic marker ADGRG6 in pancreatic adenocarcinoma: multi-omics analysis and experimental validation
doi 10.3389/fimmu.2025.1530789
- 590 views
ORIGINAL RESEARCH
Published on 21 Mar 2025
Circadian rhythm related genes identified through tumorigenesis and immune infiltration-guided strategies as predictors of prognosis, immunotherapy response, and candidate drugs in skin cutaneous malignant melanoma
doi 10.3389/fimmu.2025.1513750
- 692 views
ORIGINAL RESEARCH
Published on 20 Mar 2025
Association between oxidative balance score and all-cause and cancer-specific mortality among cancer survivors
doi 10.3389/fimmu.2025.1541675
- 593 views
BRIEF RESEARCH REPORT
Published on 17 Mar 2025
High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment
doi 10.3389/fimmu.2025.1522755
- 597 views
SYSTEMATIC REVIEW
Published on 26 Feb 2025
Significant association between systemic inflammation response index and prognosis in patients with urological malignancies
doi 10.3389/fimmu.2025.1518647
- 481 views
ORIGINAL RESEARCH
Published on 13 Feb 2025
A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes
doi 10.3389/fimmu.2025.1518102
- 1,007 views
- 1 citation
ORIGINAL RESEARCH
Published on 30 Jan 2025
Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer: a retrospective study
doi 10.3389/fonc.2025.1470445
- 531 views
ORIGINAL RESEARCH
Published on 29 Jan 2025
SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma
doi 10.3389/fimmu.2025.1507227
- 755 views
ORIGINAL RESEARCH
Published on 06 Jan 2025
The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis
doi 10.3389/fimmu.2024.1511866
- 1,161 views
ORIGINAL RESEARCH
Published on 17 Dec 2024
First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study
doi 10.3389/fonc.2024.1510278
- 1,157 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: